JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M108807200 on December 10, 2001

J. Biol. Chem., Vol. 277, Issue 7, 4713-4721, February 15, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/7/4713    most recent
M108807200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landis, M. S.
Right arrow Articles by Capone, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landis, M. S.
Right arrow Articles by Capone, J. P.

Oxysterol Activators of Liver X Receptor and 9-cis-Retinoic Acid Promote Sequential Steps in the Synthesis and Secretion of Tumor Necrosis Factor-alpha from Human Monocytes*

Mark S. LandisDagger , Hansa V. Patel, and John P. Capone§

From the Department of Biochemistry, Faculty of Health Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada

Liver X receptor alpha  (LXRalpha ), is a nuclear hormone receptor that is activated by oxysterols and plays a crucial role in regulating cholesterol and lipid metabolism in liver and cholesterol efflux from lipid-loaded macrophages. Here we show that treatment of human peripheral blood monocytes or monocytic THP-1 cells with the LXR ligand 22(R)-hydroxycholesterol (22(R)-HC), in combination with 9-cis-retinoic acid (9cRA), a ligand for the LXR heterodimerization partner retinoid X receptor (RXR), results in the specific induction of the potent pro-apoptotic and pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha ). Promoter analysis, inhibitor studies, and order-of-addition experiments demonstrated that TNF-alpha induction by 22(R)-HC and 9cRA occurs by a novel two-step process. The initial step involves 22(R)-HC-dependent induction of TNF-alpha mRNA, and intracellular accumulation of TNF-alpha protein, mediated by binding of LXRalpha /RXRalpha to an LXR response element at position -879 of the TNF-alpha promoter. Subsequent cell release of TNF-alpha protein occurs via a separable 9cRA-dependent, LXRalpha -independent step that requires de novo transcription and protein synthesis. Our findings reveal a potentially new dimension of the physiological role of LXRalpha and identify a unique multistep pathway of TNF-alpha production that may be of consequence to the normal function of LXR in monocyte/macrophages and in disease conditions such as atherosclerosis.


* This work was supported in part by the Canadian Institutes of Health Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Holds an Ontario Graduate Scholarship from the Province of Ontario.

§ To whom correspondence should be addressed: Tel.: 905-525-9140 (ext. 22184); Fax: 905-546-0800; E-mail: caponej@mcmaster.ca.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
J EndocrinolHome page
C. J Delvecchio and J. P Capone
Protein kinase C {alpha} modulates liver X receptor {alpha} transactivation
J. Endocrinol., April 1, 2008; 197(1): 121 - 130.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Fontaine, E. Rigamonti, A. Nohara, P. Gervois, E. Teissier, J.-C. Fruchart, B. Staels, and G. Chinetti-Gbaguidi
Liver X Receptor Activation Potentiates the Lipopolysaccharide Response in Human Macrophages
Circ. Res., July 6, 2007; 101(1): 40 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. P. Mooijaart, M. Kuningas, R. G. J. Westendorp, J. J. Houwing-Duistermaat, P. E. Slagboom, P. C. N. Rensen, and D. van Heemst
Liver X Receptor Alpha Associates With Human Life Span
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. G. Neels, M. Pandey, G. S. Hotamisligil, and F. Samad
Autoamplification of Tumor Necrosis Factor-{alpha}: A Potential Mechanism for the Maintenance of Elevated Tumor Necrosis Factor-{alpha} in Male but Not Female Obese Mice
Am. J. Pathol., February 1, 2006; 168(2): 435 - 444.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Bernstein, C. M. Payne, K. Kunke, C. L. Crowley-Weber, C. N. Waltmire, K. Dvorakova, H. Holubec, C. Bernstein, R. R. Vaillancourt, D. A. Raynes, et al.
A proteomic study of resistance to deoxycholate-induced apoptosis
Carcinogenesis, May 1, 2004; 25(5): 681 - 692.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. R. Steffensen and J.-A. Gustafsson
Putative Metabolic Effects of the Liver X Receptor (LXR)
Diabetes, February 1, 2004; 53(90001): S36 - 42.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. K. Tangirala, E. D. Bischoff, S. B. Joseph, B. L. Wagner, R. Walczak, B. A. Laffitte, C. L. Daige, D. Thomas, R. A. Heyman, D. J. Mangelsdorf, et al.
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
PNAS, September 3, 2002; 99(18): 11896 - 11901.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.